AT
ZBH icon

Arlington Trust’s Zimmer Biomet ZBH Stock Holding History

Arlington Trust’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344 Hold
4
– – ﹤0.01% 811
2026
Q1 		$362 Buy
+4
New +$367 ﹤0.01% 804

Other funds holding ZBH

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return
QAM
QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
NCM
Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Arlington Trust's ZBH Position: Q2 2026 in Review

Arlington Trust held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 4 shares worth $344. The position accounts for ﹤0.01% of the portfolio, ranked #811.

Arlington Trust first reported a position in ZBH in Q1 2026 and has held it in 2 quarters since. The position peaked at $362 in Q1 2026. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Arlington Trust held 4 shares of Zimmer Biomet worth $344 as of Q2 2026.
  • Arlington Trust left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #811 holding.
  • Arlington Trust first reported a position in Zimmer Biomet in Q1 2026 and has held it in 2 quarters since.
  • Arlington Trust's Zimmer Biomet position peaked at $362 in Q1 2026.
  • 132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.